Yahoo Finance • 4 months ago
MINNEAPOLIS, Jan. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) had the honor of welcoming presentations from leading scientists from two major biopharmaceutical companies, Pfizer and Sanofi, at the WCBP conference held in... Full story
Yahoo Finance • 5 months ago
MINNEAPOLIS, Dec. 20, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate™ GMP iPSC Expansion Medium, An... Full story
Yahoo Finance • 5 months ago
MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore, a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics, have been awarded Innosuisse funding for an innovation project.... Full story
Yahoo Finance • 6 months ago
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund outperformed the Russell 2000... Full story
Yahoo Finance • 6 months ago
Key Insights Bio-Techne's estimated fair value is US$57.87 based on 2 Stage Free Cash Flow to Equity With US$63.58 share price, Bio-Techne appears to be trading close to its estimated fair value The US$77.69 analyst price target for TECH... Full story
Yahoo Finance • 7 months ago
Kitted assays for clinical laboratories streamline the detection of challenging genes and variants to improve results for underrepresented populations MINNEAPOLIS , Nov. 2, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today a... Full story
Yahoo Finance • 7 months ago
Bio-Techne Corporation (NASDAQ:TECH) shareholders might be concerned after seeing the share price drop 26% in the last quarter. But at least the stock is up over the last five years. However we are not very impressed because the share pric... Full story
Yahoo Finance • 7 months ago
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund declined 6.05% (Institutional Shares) in the quarter compared to a... Full story
Yahoo Finance • 8 months ago
MINNEAPOLIS, Sept. 27, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) was pleased to host presentations by three industry experts yesterday at the CASSS CE Pharm conference in Philadelphia, PA. These industry experts highlighte... Full story
Yahoo Finance • 9 months ago
Bio-Techne Corp (NASDAQ:TECH) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares currently priced at 79.07, Bio-Techne Corp has witnessed a decline of... Full story
Yahoo Finance • 9 months ago
MINNEAPOLIS, Aug. 24, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2023 Investor Day on Friday, September 8, 2023, starting at 8:30 a.m. EDT. The meeting will take place at the JW... Full story
Yahoo Finance • a year ago
Lunaphore’s co-founders, CEO Ata Tuna Ciftlik, CMO Déborah Heintze, and CTO Diego Gabriel By Daniella Parra Swiss life sciences company Lunaphore Technologies SA has agreed to be acquired by Bio-Techne Corporation, (NASDAQ:TECH) a global... Full story
Yahoo Finance • a year ago
Bio-Techne Corporation (NASDAQ: TECH) has agreed to acquire Lunaphore Inc with undisclosed deal terms. Lunaphore, founded in 2014 and based in Tolochenaz, Switzerland, develops fully automated spatial biology solutions using precision mic... Full story
Yahoo Finance • a year ago
Halfway through 5-year study, ExoDx Prostate Test offers more accurate stratification of high- and low-risk patients compared to standard of care MINNEAPOLIS, May 18, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announ... Full story
Yahoo Finance • a year ago
MINNEAPOLIS, May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets Global Healthcare Conferenc... Full story
Yahoo Finance • a year ago
MINNEAPOLIS, May 3, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2023. The quarterly dividend will be pay... Full story
Yahoo Finance • a year ago
MINNEAPOLIS, May 3, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023. Third Quarter FY2023 Highlights Third quarter organic revenue increased by 3%... Full story
Yahoo Finance • a year ago
MINNEAPOLIS, Feb. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cell Signaling Technology (CST) announced today the addition of Simple Western™ validation to CST antibodies. This will allow researchers in various disci... Full story
Yahoo Finance • a year ago
The top healthcare stocks include Azenta Inc. for best value, McKesson Corp. for fastest growth, and Signify Health Inc. for most momentum. Continue reading... Full story
Yahoo Finance • 2 years ago
Study indicates that noninvasive exosome-based liquid biopsy would be feasible for monitoring health and disease in people traveling in space MINNEAPOLIS, Oct. 18, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced... Full story
Home
Money Search
Trending Sports
Gallery
Shop
Blog
Examples
Data & Glossary
Elements of Bball
Harden Maze
About
